TY - JOUR T1 - Medicines optimisation: time to review fibrates? JF - Drug and Therapeutics Bulletin JO - Drug Ther Bull SP - 146 LP - 146 DO - 10.1136/dtb.2019.000066 VL - 57 IS - 10 AU - Teck K Khong Y1 - 2019/10/01 UR - http://dtb.bmj.com/content/57/10/146.abstract N2 - In grappling with the challenge of maximising health outcomes from increasingly stretched and finite resources, healthcare systems have been developing and implementing strategies to improve the use of medicines. In the NHS over the past decade, there has been growing attention on medicines optimisation. Defined as ‘a person-centred approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines’, medicines optimisation has an emphasis on safety, governance, professional collaboration and patient engagement.1 2 For the practitioner trying to do the best for their patient, this may sound somewhat like an initiative imposed by a top-down, management- and process-heavy organisation unresponsive to the realities of daily operational issues, bureaucracy and the pressures faced by … ER -